Why the gap between policy and lived reality continues to shape the opioid epidemic, and what the settlement era can do about it.
An Opportunity to Shape the Future
The Two Opioid Crises
There are two versions of the opioid crisis.
One exists in the policy world.
It is the world of interagency strategies, CDC guidance documents, prescription drug monitoring programs, enforcement memoranda, litigation settlements, and funding allocations. It is structured, deliberate, and documented. Policies move through review processes, public comment periods, legal analysis, and implementation plans.
Much of my professional life has been spent in this world.
But there is another opioid crisis.
It is the emergency department at 2 a.m. when overdose patients arrive in clusters. It is the rural county trying to recruit its first addiction specialist. It is the grandparent raising grandchildren after the death of an adult child. It is the family that receives a devastating phone call in the middle of the night.
This crisis is less orderly. It doesn’t follow administrative timelines. It doesn’t wait for guidance documents to be published or grant cycles to begin.
And for much of the last four decades, these two realities have moved at different speeds.
That gap may be one of the most important lessons of the opioid epidemic.
When Policy Lags Behind Reality
One of the most striking features of the overdose crisis is how consistently policy has struggled to keep pace with changing conditions on the ground.
Researchers have shown that overdose mortality has followed a remarkably consistent long-term upward trajectory dating back to the late 1970s. Yet for much of that period, policy responses often focused on the most visible manifestation of the problem rather than the broader systems producing it.
During the early years of the modern opioid epidemic, policymakers understandably focused on prescribing.
Prescription drug monitoring programs expanded. CDC prescribing guidance was developed. Enforcement efforts targeted illicit prescribing.
Many of these interventions were necessary.
But while policymakers were focused on reducing inappropriate prescribing, something else was already happening.
Individuals who had developed opioid use disorder did not simply stop using drugs when prescribing became more restricted. Drug markets adapted. People shifted from prescription opioids to heroin, and eventually to fentanyl.
The system evolved faster than the policy response.
This is the first lesson of the opioid epidemic:
Policy often assumes stability. Reality adapts.
Success in one domain can unintentionally create vulnerabilities in another when systems are changing rapidly.
The Infrastructure Problem
There was another challenge that many early policy responses struggled to recognize.
Not all communities started from the same place.
Some communities had hospitals, addiction treatment programs, transportation systems, and a robust healthcare workforce.
Others had very little.
The Affordable Care Act expanded insurance coverage. Mental health parity laws sought to improve access to behavioral healthcare. Yet neither policy could instantly create addiction specialists, recovery support networks, or treatment capacity where those resources did not already exist.
As a result, communities facing the greatest burden often had the fewest tools available to respond.
A one-size-fits-all policy framework was always going to produce uneven outcomes because the underlying infrastructure was uneven.
The lesson wasn’t simply that more funding was needed.
It was that capacity matters.
The Litigation Era Changed the Conversation
The litigation era represented a different kind of policy response.
For the first time, the epidemic was addressed not only through public health and criminal justice systems but through the legal system.
The opioid settlements produced an extraordinary outcome: long-term funding dedicated specifically to opioid abatement.
They also forced a broader recognition that this was not merely a collection of local problems. It was a nationwide systems failure.
Yet even here, a familiar challenge emerged.
Settlement agreements created funding streams. They did not automatically create treatment capacity.
A county may receive new resources, but what does opioid abatement mean if there are no providers available to deliver services? What happens when local governments face workforce shortages, administrative turnover, or limited implementation capacity?
The answer is that money alone cannot build systems.
Funding is necessary.
Capacity is what makes funding useful.
The Most Important Function of Settlement Funding May Not Be What We Expected
Much of the conversation surrounding opioid settlements focuses on how quickly money is being spent.
That concern is understandable as we continue to struggle with overdose morbidity and mortality.
But speed is not the only metric that matters.
Increasingly, I believe one of the most important functions of settlement funding is not expansion.
It is stabilization.
In many communities, settlement dollars are doing three things simultaneously:
Expanding treatment and recovery services.
Preventing fragile programs from collapsing.
Providing multi-year predictability in an otherwise uncertain policy environment.
This stabilization role is rarely discussed.
It is also increasingly important.
Federal priorities change. Grant programs are subject to regular appropriations. Medicaid policies evolve.
Settlement funding, by contrast, provides something rare in American public policy: structured time.
That time creates opportunities not just to launch programs, but to build systems.
The Next Challenge Is Alignment
Today, many communities are no longer facing a pure resource problem.
They are facing an alignment problem.
Funding exists.
Need exists.
But implementation capacity varies dramatically.
Some jurisdictions have academic medical centers, established treatment networks, recovery organizations, and strong public health infrastructure.
Others are still trying to recruit their first addiction specialist.
Some have grant writers and data analysts.
Others have a public health director doing three jobs at once.
If settlement implementation ignores those differences, it risks reproducing the same inequities that helped shape the crisis.
The question is not simply how quickly we spend settlement dollars.
The question is whether the communities furthest from care are actually getting closer to it.
What Success Should Look Like
For decades, policymakers have measured success through outputs.
Dollars allocated.
Programs created.
Services delivered.
Those metrics matter.
But they are incomplete.
Success should be measured by whether communities become more capable of responding to future challenges.
Because another challenge will come.
Drug markets evolve.
Social conditions change.
Public health threats emerge.
The communities that fare best are not always those with the most resources. They are the communities with the greatest capacity to adapt.
That is why the most important legacy of the settlement era may not be the number of programs funded or the dollars spent.
It may be something less visible.
Stronger systems.
Systems capable of responding earlier.
Systems capable of reaching people who have historically been left behind.
Systems capable of surviving shifts in political priorities and funding streams.
If we can build those systems, then years from now the defining achievement of the settlement era will not be the money.
It will be the capacity, resiliency, and long-term infrastructure that has been built.